Life environmental factors in sporadic Alzheimer's disease
Mori, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl: 52-55
2004
ISSN/ISBN: 0047-1852 PMID: 15011319 Document Number: 567718
Document emailed within 1 workday
Related Documents
Tol, J.; Roks, G.; Slooter, A.J.; van Duijn, C.M. 1999: Genetic and environmental factors in Alzheimer's disease Revue Neurologique (Paris) 155(Suppl 4): S10-S16Pyles, R.B. 2001: The association of herpes simplex virus and Alzheimer's disease: a potential synthesis of genetic and environmental factors Herpes: the journal of the IHMF 8(3): 64-68
Xing, M.; Ai, Y-mei.; He, R-lian.; Gao, J-wei.; Song, P-ping.; Wang, X-cheng.; Gao, C-hong.; Zhang, H-min.; Yu, H-mei. 2012: Current status and influencing factors regarding quality of life among patients with Alzheimer's disease Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 606-609
Kowalska, A.; Florczak, J.; Pruchnik-Wolińska, D.; Kraszewski, A.; Wender, M. 1998: Apolipoprotein e genotypes in sporadic early and late-onset Alzheimer's disease Archivum Immunologiae et Therapiae Experimentalis 46(3): 177-181
Sánchez Rodríguez, J.L.; Rodríguez álvarez, M. 2004: Neuropsychologic performance and depressed mood in sporadic late onset Alzheimer disease Revista de Neurologia 38(7): 625-630
Nizamutdinov, I.I.; Andreeva, T.V.; Stepanov, V.A.; Marusin, A.V.; Rogaev, E.I.; Zasedatelev, A.S.; Nasedkina, T.V. 2013: Biochip for determination of genetic markers of sporadic Alzheimer's disease in the Russian Slavic population Molekuliarnaia Biologiia 47(6): 949-958
Katayama, T.; Manabe, T.; Tohyama, M. 2003: Recent progress in 'HMGA1a' which causes aberrant splicing of Presenilin-2 pre-mRNA in sporadic Alzheimer's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 61(4): 677-688
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Coon, K.D.; Myers, A.J.; Craig, D.W.; Webster, J.A.; Pearson, J.V.; Lince, D.Hu.; Zismann, V.L.; Beach, T.G.; Leung, D.; Bryden, L.; Halperin, R.F.; Marlowe, L.; Kaleem, M.; Walker, D.G.; Ravid, R.; Heward, C.B.; Rogers, J.; Papassotiropoulos, A.; Reiman, E.M.; Hardy, J.; Stephan, D.A. 2007: A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease Journal of Clinical Psychiatry 68(4): 613-618
Murakami, S. 2012: Risk factors of breast cancer (life style and environmental factors) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 50-54
Cocco, P.L.; Caperna, A.; Vinci, F. 2003: Occupational risk factors for the sporadic form of Creutzfeldt-Jakob disease La Medicina del Lavoro 94(4): 353-363
Josipovic-Jelic, Z.; Soljan, I. 2009: Alzheimer's disease patients: quality of life in the Republic of Croatia Bratislavske Lekarske Listy 110(11): 705-709
Le Port, A.ès.; Watier, L.; Cottrell, G.; Ouédraogo, S.; Dechavanne, C.él.; Pierrat, C.; Rachas, A.; Bouscaillou, J.; Bouraima, A.; Massougbodji, A.; Fayomi, B.; Thiébaut, A.; Chandre, F.; Migot-Nabias, F.; Martin-Prevel, Y.; Garcia, A.é; Cot, M. 2011: Infections in infants during the first 12 months of life: role of placental malaria and environmental factors PLOS one 6(11): E27516
Leuba, G.; Savioz, A. 1997: Alzheimer's disease and genetic factors Revue Medicale de la Suisse Romande 117(11): 871-878
Barranco-Quintana, J.L.; Allam, M.F.; Del Castillo, A.S.; Navajas, R.F.-C. 2005: Risk factors for Alzheimer's disease Revista de Neurologia 40(10): 613-618
Martín-González, R.; Ortiz de Salazar, A.; Peris-Martí, A.; Valiente-Ibiza, E.; Sala-Corbí, A. 2000: Life events, quality of life and social support prior to acute cerebral vascular disease, as predictive factors of the quality of life and functional state following stroke Revista de Neurologia 30(8): 707-711
Babić, T.; Mahović Lakusić, D.; Sertić, J.; Petrovecki, M.; Stavljenić-Rukavina, A. 2004: ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study Collegium Antropologicum 28(1): 199-204
Mackell, J.A.; Ferris, S.H.; Mohs, R.; Schneider, L.; Galasko, D.; Whitehouse, P.; Schmitt, F.; Sano, M.; Thal, L.J. 1997: Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11 Suppl. 2: S65-S69
Morris, J.C.; Edland, S.; Clark, C.; Galasko, D.; Koss, E.; Mohs, R.; van Belle, G.; Fillenbaum, G.; Heyman, A. 1993: The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43(12): 2457-2465
Fukatsu, R.; Tsuzuki, K.; Hayashi, Y.; Takamaru, Y.; Sasaki, N.; Yoshida, T.; Hatakeyama, Y.; Fuji, N.; Takahata, N. 1997: Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes Hokkaido Journal of Medical Science 72(1): 3-11